Get Permission Bhavsar and Upadhyay: Study of lung cancer patients with the help of bronchoscopy and evaluating the lung cancer patterns in such patients


Introduction

worldwide in both genders combined, lung cancer is the on the whole frequently diagnosed cancer and the important cause of cancer death.1 Flexible fiber -optic bronchoscopy (FOB) is very safe and highly sensitive investigation for patients suspecting lung malignancy.2 Beside histology, cytological diagnosis is possible with the help of such bronchoscopy. In modern days, immense attention in the histological categorization of lung cancer in consideration of newer histology guided therapeutic modalities and genomic classification of lung carcinoma. In western countries and the majority of the Asian countries, adenocarcinoma has outshines squamous cell carcinoma in terms of occurrence. This change appears to be attributable somewhat to the transformed smoking pattern and rising incidence of lung cancer in females and non- smokers.3,4 Tobacco smoking constitutes the single most important carcinogen for lung cancer.

The expected diagnostic yield of flexible fiber -optic bronchoscopy depends on location and distribution of the tumour.5 Central and endobronchial lesions have the highest diagnostic yield. The use of transbronchial needle aspiration (TBNA) and bronchoalveolar lavage (BAL) can augment the yield substantially. Biopsy of solid lesion can assist in analysis of over 60% of cases but the success rates are lesser if the lesion is intramural in place and falls further if the lesion is distant from idea of bronchoscopy. Since its introduction, published rates of complication from flexible fiber-optic bronchoscopy have ranged from <0.1 to 11%, with mortality generally reported between 0 and 0.1%.6

Materials and Methods

Present study was observational prospective study completed over a time of one year at a tertiary care centre of western India. In this study all patients with suspected lung cancer and subjected to bronchoscopy were recruited in the study after taking informed consent. A detailed clinical history, physical examinations was done before hand and necessary investigations were carried out for example chest radiography, CT scan of thorax, haematological examination, sputum for AFB, etc. Patients with HIV AIDS were excluded from the study. Children less than 18 years of age, patients who did not give consent for the study and patients who had absolute contraindications for performing fibreoptic bronchoscopy were excluded from the study.

Results and Discussion

Greater than 28% of every cancer mortality each year are due to lung cancer.7 Lung cancer stands for the chief reason of cancer death all over the world, with 1.4 million deaths every year due to lung cancer.8 As per WHO figures, Egypt has the maximum death rate, prevalence, and incidence in North Africa.9

This study included 75 patients with primary malignancy of the lung (59 male and 16 female patients). Majority of the patients in this study were in age group of 51 to 70 years (58.66%). (Figure 1) Cough was the most common symptom present in 67(89.33%) of the patients followed by dyspnoea 40(53.33%), chest pain 34(45.33%), haemoptysis 33(44.0%), weight loss 23 (30.66%) and hoarseness of voice 16(21.33%). Fever was present in 10 patients (13.33%) while dysphagia was observed in 4(5.33%) patients. Clinical signs such as clubbing were present in 32(42.66%) patients and cervical lymphadenopathy was present in 20 (26.66%) patients. In this present study, 52(69.33%) patients were current or former smokers and 23(30.66%) were never-smokers, finding of this study were in harmony with the findings of Safwat et al.10

Figure 1

Distributionof patients according to age and gender

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7a16cb78-5218-4e4e-9b17-cebc6963cd3a/image/ba10fd5f-07ac-45d9-a21a-7c798bfc6678-uimage.png

Table 1
Broncoscopic Procedure done Performed in No of Patients Positive for malignant cells in following number of Patients Percentage (%)
Broncho alveolar lavage (BAL) 75 42 56.0%
Endobronchial Biopsy 58 47 81.03%
Trans-bronchial needle aspiration (TBNA) 6 3 50.0%
Sputum Cytology (Immediately Post Bronchoscopy) 60 6 10.0%

Distribution of patients according to broncoscopic procedures

Table 2
Anatomical site at which lesion was encountered during bronchoscopy Number of Cases %
In trachea 2 2.667%
Near carina 21 28.000%
In Main bronchi 27 36.000%
In Upper lobe bronchus 14 18.667%
In lower lobe bronchi or bronchus intermedius 11 14.667%

Anatomical site at which lesion was encountered during bronchoscopy

Table 3
Macroscopic presentation of lesion seen in bronchoscopy Number of Cases %
End bronchial lesion 28 37.333%
Luminal Narrowing 19 25.333%
Mucosal infiltration 4 5.333%
External Compression 17 22.667%
Combination of above 7 9.333%

Macroscopic presentation of lesion seen in bronchoscopy

Figure 2
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/7a16cb78-5218-4e4e-9b17-cebc6963cd3a/image/7d09c7ea-5ef6-43be-b9dc-ccf46c1488db-uimage.png

Bronchoscopy guided endo-bronchial biopsy was more specific than BAL cytology. 27 (36.0%) patients were diagnosed based on only endo-bronchial tissue biopsy histopathology report. 20 patients (26.66%) were diagnosed by both BAL cytology and endo-bronchial biopsy histopathology examination. 17(22.66%) patients were diagnosed by only BAL cytology. 2(4.4%) patients were diagnosed by both BAL cytology and TBNA. One patient (1.33%) was diagnosed exclusively on TBNA report. Post bronchoscopy sputum cytology and BAL both together helped to arrive at diagnosis in 2 (2.66%) patients. 4 patients (5.33%) was diagnosed by post bronchoscopy sputum cytology only without the help of any other reports.

Table 4
Variables Squamous Cell Ca (n=22) Adeno Carcinoma (n=20) Odds ratio 95% confidence limits Measure of Association (p value)
Gender Male 16 13 1.05 0.96, 1.36 0.05*
Female 6 7
Smoking Present 17 14 1.25 0.98, 1.61 0.01*
Absent 5 6
Metastasis Present 17 15 1.30 1.07, 1.69 0.001*
Absent 5 5
Bronchoscopic procedure BAL Cytology 13 11 1.02 0.89, 1.67 0.02*
Bronchial biopsy H&P 9 9

Association of type of cancer with gender, smoking, metastasis and bronchoscopic procedure

In this present study, 52(69.33%) patients were current or former smokers and 23(30.66%) were never-smokers. Out of smokers, 90.1% smokers had smoking history of ≥ 20 pack years of smoking. No one of female was smokers. Amid Smokers, Squamous cell carcinoma was more frequent histological subtype found. Findings of this were also in harmony with the research of Kshatriya et al11 who found among 25 cases of malignancy, 19 smokers and six nonsmokers. Squamous cell carcinoma was observed more in smokers, which was in agreement with findings of Mazharand Jehanzeb.12

Metastasis was found in 82.5% patients at the time of diagnosis. In lungs, upper lobe was most commonly involved, wherein left upper lobe was most commonly involved. For proper staging of the tumor patients were referred to the nearby cancer institute where the further management of theirs was carried out. Finding of this study were in harmony with Rabahiet al13 who describe the location of noticeable tumors in 169 cases; the tumor was there in the upper lobe bronchi in 48% of cases.

In this present study, only 3(4%) out of 75 patients had compli cations. There were no serious complications and there was zero mortality. 2 patients had bleeding from biopsy site during endo-bronchial biopsy which was easily controlled with ice-cold 0.9% normal saline lavage. 1 patient developed bronchospasm who was a known case of COPD. Bronchospasm was controlled within short period with inhaled bronchodilators (Levosalbutamol) which were administered soon after the patient was shifted to short general anaesthesia (propofol) by expert standby anaesthetist and then the procedure was carried out without further complications.

Table 4 explains association of type of cancer with gender, smoking, metasta sis and bronchoscopic procedure. It was observed that males had a significant (p ≤ 0.05) higher risk ratio of squamous cell and Adeno Carcinoma contrast to females. Smoking was more linked with squamous cell carcinoma and differences between two carcinoma groups were significant statistically. (Odds ratio: 1.25) (p≤0.05) Similarly, metastasis was more associated with squamous cell carcinoma and it was also statistically significant (Odds ratio: 1.30). There was statistically significant differentiation observed between the bronchoscopic procedures like BAL cytology and Bronchial Biopsy in diagnosis of squamous and adenocarcinoma. (p≤0.05) (Odds ratio: 1.02)

Conclusion

Premature recognition of lung cancer in the airway is vital for evading the multi-step sequence to insidious cancer. Even though tissue biopsy is the gold standard for analysing neoplastic and preneoplastic disease, bronchoscopic technologies are the safest and most precise apparatus to assess both central and distal airway mucosa. Appropriate screening and premature diagnostic methods should be functional on a huge scale to discover out alleged patients who are at risk of rising lung cancer.

Source of funding

None.

Conflict of interest

None.

Acknowledgment

None.

References

1 

F Bray J Ferlay I Soerjomataram R L Siegel L A Torre A Jemal Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer J Clin201868394424

2 

M P Rivera A C Mehta M M Wahidi Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancerChest201314314265American College of Chest Physicians evidence-based clinical practice guidelines

3 

H A Wakelee E T Chang S L Gomez Lung cancer incidence in never smokersJ Clin Oncol2007255472478

4 

J Lortet-Tieulent I Soerjomataram J Ferlay M Rutherford E Weiderpass F Bray International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in womenLung Cancer20148411322

5 

S Gasparini M Ferrety E Such Integration of transbronchial and percutaneous approach in the diagnosis of peripheral pulmonary nodules or masses: experience with 1027 consecutive casesChest19951081131137

6 

S David R Kathleen P Thomas Complications of bronchoscopy: A concise synopsisInt J Crit Illn Inj Sci201553189195

7 

Cancer facts and Figures: American Cancer Society; Atlanta: Lung cancer deaths Inc. 2016; p. 17/72

8 

GLOBOCON Lung cancer incidence and mortality worldwide in 2008http:// globocan. iarc. fr/ factsheets/ cancers/ lung. asp. [Accessed 1 August 2013].

9 

J Ferlay A Brayf D M Parkin P Pisani - Globocan FR/globocan). fiber optic bronchoscopy on arterial oxygen saturationJ Islamic Med Assoc (USA)20003253033lyon, IRAC PressIARC Cancer base

10 

T Safwat H Samy H Helmy Lung cancer presentations and sites in fiber optic bronchoscopyCairo: Faculty of Medicine20176989

11 

R M Kshatriya N V Khara R Paliwal S Patel Role of flexible fiber-optic bronchoscopy in the diagnosis of pulmonary diseases in rural-based tertiary hospitalInt J Med Sci Public Health india20165873876

12 

M Mazhar Ali Jehanzeb Fibro optic bronchoscopy diagnostic outcome and complications in patients with hilar and para hilar lung opacitiesProfessional Med J200613384390

13 

M F Rabahi A A Ferreira B P Reciputti T O Matos S A Pinto Fiber optic bronchoscopy findings in patients diagnosed with lung cancerJ Bras Pneumol201238445451



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File  


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijirm.2019.053


Article Metrics






Article Access statistics

Viewed: 1668

PDF Downloaded: 751



Medical Abbreviation List